Unsure which funding opportunity is right for you? Use our investor matching tool to help you on to your next stepFind investor
Takes less than ~2 min to complete
HCL Technologies is a next-generation global technology company that helps enterprises reimagine their businesses for the digital age. Their technology products, services and engineering are built on four decades of innovation, with a world renowned management philosophy, a strong culture of invention and risk-taking, and a relentless focus on customer relationships. With a worldwide network of R&D, innovation labs and delivery centers, and 137,000+ ‘Ideapreneurs’ working in 44 countries, HCL serves leading enterprises across key industries, including 250 of the Fortune 500 and 650 of the Global 2000. HCL generated consolidated revenues of USD 8.6 billion for for Financial Year Ended 31st Mar, 2019. HCL offer an integrated portfolio of products, solutions, services, and IP through their Mode 1-2-3 strategy built around Digital, IoT, Cloud, Automation, Cybersecurity, Analytics, Infrastructure Management and Engineering Services, amongst others, to help enterprises reimagine their businesses for the digital age. The Ecosystem Innovation Program is being run by HCLs Corporate Venturing team (ETO) on bringing open innovation initiatives where they work with customers on emerging technologies, business trends and use cases. HCL's regional leads work with start-ups through established VC, consulate trade missions and other channels to continuously scout for collaboration initiatives across industries. You can contact us to learn more about their open innovation success stories. Investment from HCL's side will not be equity in start-ups but the time and effort put into joint customer centric innovation programs.
Largest network of startup investors in Denmark located at DTU - the heart of tech, innovation and research. The network has reached critical mass and an investment capacity of 500 mio. DKK, making it highly active with weekly pitches, new investments and investor education. The secretariat is run by the most experienced people in the danish angel industry.
A European venture capital firm, dedicated to investments in the field of life science. Their investment strategy is focused on diseases with high unmet medical needs and breakthrough therapies. Through their investments, HealthCap wants to change medical practice and the lives of patients.
The venture debt product is a loan aimed at mature startups, who already have (or are in the process) of securing equity funding from a venture capital fund. Apart from the right to receive payment of interests and the principal, the lender (Vækstfonden) will receive a few warrants, by which Vækstfonden can subscribe for shares in the company.